FDA finalizes guidance on quantitative efficacy and risk info for DTC promotional labeling, ads
Regulatory NewsJeff Craven
Advertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsRegulatory NewsJeff CravenAdvertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticals